Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Other Working Capital Changes (2017 - 2025)

Historic Other Working Capital Changes for Sensus Healthcare (SRTS) over the last 9 years, with Q3 2025 value amounting to -$2.8 million.

  • Sensus Healthcare's Other Working Capital Changes fell 7689.44% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$124000.0, marking a year-over-year increase of 9442.2%. This contributed to the annual value of $619000.0 for FY2024, which is 11890.08% up from last year.
  • As of Q3 2025, Sensus Healthcare's Other Working Capital Changes stood at -$2.8 million, which was down 7689.44% from -$1.5 million recorded in Q2 2025.
  • Sensus Healthcare's 5-year Other Working Capital Changes high stood at $3.4 million for Q1 2023, and its period low was -$3.0 million during Q3 2023.
  • Its 5-year average for Other Working Capital Changes is -$27631.6, with a median of -$291000.0 in 2021.
  • As far as peak fluctuations go, Sensus Healthcare's Other Working Capital Changes skyrocketed by 142751.09% in 2022, and later tumbled by 43239.44% in 2023.
  • Sensus Healthcare's Other Working Capital Changes (Quarter) stood at -$229000.0 in 2021, then soared by 1427.51% to $3.0 million in 2022, then plummeted by 131.58% to -$960000.0 in 2023, then surged by 296.04% to $1.9 million in 2024, then crashed by 251.33% to -$2.8 million in 2025.
  • Its Other Working Capital Changes was -$2.8 million in Q3 2025, compared to -$1.5 million in Q2 2025 and $2.3 million in Q1 2025.